|
|
|
|
Vol. 62, Issue 4, 847-855, October 2002
Departments of Pharmacology (T.S., T.Y., S.S., H.Y., H.K., S.M.,
A.W.) and Surgery (T.S., T.O.), Miyazaki Medical College, Miyazaki,
Japan
Treatment (
6 h) of cultured bovine adrenal chromaffin cells
with geldanamycin (GA) or herbimycin A (HA), an inhibitor of the 90-kDa
heat-shock protein (Hsp90) family, decreased cell surface 125I-insulin binding. The effect of GA was concentration
(EC50 = 84 nM)- and time
(t1/2 = 8.5 h)-dependent; GA (1 µM for 24 h) lowered the Bmax value
of 125I-insulin binding by 80%, without changing the
Kd value. Western blot analysis showed that
GA (
3 h) lowered insulin receptor (IR) level by 83%
(t1/2 = 7.4 h;
EC50 = 74 nM), while raising IR precursor level by
100% (t1/2 = 7.9 h;
EC50 = 300 nM). Pulse-label followed by reducing and
nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis
revealed that monomeric IR precursor (~190 kDa) developed into the
homodimeric IR precursor (~380 kDa) and the mature
2
2 IR (~410 kDa) in nontreated cells,
but not in GA-treated cells; in GA-treated cells, the
homodimerization-incompetent form of monomeric IR precursor was
degraded via endoplasmic reticulum (ER)-associated protein degradation.
Immunoprecipitation followed by immunoblot analysis showed that IR
precursor was associated with calnexin (CNX) to a greater extent in
GA-treated cells, compared with nontreated cells. GA had no effect on
IR mRNA levels and internalization rate of cell surface IRs. In
GA-treated cells, insulin-induced tyrosine phosphorylation of insulin
receptor substrate-1 (IRS-1) was attenuated by 77%, with no change in
IRS-1 level. Thus, inhibition of the Hsp90 family by GA or HA
interrupts homodimerization of monomeric IR precursor in the ER and
increases retention of monomeric IR precursor with CNX; this event
retards cell surface expression of IR and attenuates insulin-induced
activation of IRS-1.
This article has been cited by other articles:
![]() |
V. L. Vega and A. De Maio Increase in Phagocytosis after Geldanamycin Treatment or Heat Shock: Role of Heat Shock Proteins J. Immunol., October 15, 2005; 175(8): 5280 - 5287. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoo, T. Saitoh, S. Shiraishi, T. Yanagita, T. Sugano, S.-I. Minami, H. Kobayashi, and A. Wada Distinct Effects of Ketone Bodies on Down-Regulation of Cell Surface Insulin Receptor and Insulin Receptor Substrate-1 Phosphorylation in Adrenal Chromaffin Cells J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 994 - 1002. [Abstract] [Full Text] [PDF] |
||||